OSI PHARMACEUTICALS (NASDAQ:OSIP)
32.79
0.07 (0.21%)
| OSI PHARMACEUTICALS (NASDAQ:OSIP) Delayed : |
| Previous Close |
$32.86 |
|
52 Week High |
$43.00 |
 |
| Open |
$33.01 |
|
52 Week Low |
$27.01 |
| Day High |
$33.05 |
|
P/E |
5.16 |
| Day Low |
$32.50 |
|
EPS |
$6.35 |
| Volume |
346,990 |
|
|
|
| More OSIP Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on OSIP
-
Nov 17, 2009 08:19 AM
OSI Pharma (OSIP) volume and volatility increases into Tarceva committee review
-
Nov 16, 2009 11:37 AM
ODAC to Review Using OSI Pharma's (OSIP) Tarceva as First-Line Therapy for Patients with Advanced Non-Small Cell Lung Cancer
-
Oct 21, 2009 10:16 AM
Galleon Shuttered On Insider Trading Charges
-
Oct 20, 2009 01:15 PM
Trading Radar for 10/21: Boeing (BA), eBay (EBAY), Wells Fargo (WFC), US Bancorp (USB), Eli Lilly (ELY), St. Jude Medical (STJ) Report
-
Oct 15, 2009 08:55 AM
OSI Pharma (OSI) and Roch Announce Tarceva Net Sales; ATLAS Data Sweep
View All Reports
-
Nov 19, 2009 10:49AM
OSI Pharmaceuticals to Webcast its R&D Analyst Day on Thursday, December 3rd
-
Nov 16, 2009 10:54AM
OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
-
Nov 9, 2009 10:00AM
OSI Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday, November 17, 2009
-
Oct 27, 2009 11:00AM
OSI Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference on Tuesday, November 3, 2009
-
Oct 21, 2009 04:05PM
OSI Pharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
View All Press Releases
StreetInsider Reports on OSIP by Category
Comments on recent OSIP articles
Comments on OSIP
No comments are currently available.
on Feb 20, 2008
at 03:42 PM INSM A $3.00 dollar stock trading below a $1.00.
Article: Analyst Call of the Year: Collins Stewart on Encysive (ENCY)